Does global plaque burden measured by age- and sex-specific segment involvement score percentiles on CCTA predict major adverse cardiovascular events?
Age- and sex-specific nomograms of global plaque burden on CCTA independently predict major cardiac events, providing a pragmatic tool for risk stratification.
Background— Age-adjusted coronary artery disease (CAD) burden identified on coronary computed tomography angiography predicts major adverse cardiovascular event (MACE) risk; however, it seldom contributes to clinical decision making because of a lack of nomographic data. We aimed to develop clinically pragmatic age- and sex-specific nomograms of CAD burden using coronary computed tomography angiography and to validate their prognostic use. Methods and Results— Patients prospectively enrolled in phase I of the CONFIRM registry (Coronary CT Angiography Evaluation for Clinical Outcomes) were included (derivation cohort: n=21,132; 46% female) to develop CAD nomograms based on age–sex percentiles of segment involvement score (SIS) at each year of life (40–79 years). The relationship between SIS age–sex percentiles (SIS%) and MACE (all-cause death, myocardial infarction, unstable angina, and late revascularization) was tested in a nonoverlapping validation cohort (phase II, CONFIRM registry; n=3030, 44% female) by stratifying patients into 3 SIS% groups (≤50th, 51–75th, and >75th) and comparing annualized MACE rates and time to MACE using multivariable Cox proportional hazards models adjusting for Framingham risk and chest pain typicality. Age–sex percentiles were well fitted to second-order polynomial curves (men: R 2 =0.86±0.12; women: R 2 =0.86±0.14). Using the nomograms, there were 1576, 965, and 489 patients, respectively, in the ≤50th, 51–75th, and >75th SIS% groups. Annualized event rates were higher among patients with greater CAD burden (2.1% 95% confidence interval: 1.7%–2.7%, 3.9% 95% confidence interval: 3.0%–5.1%, and 7.2% 95% confidence interval: 5.4%–9.6% in ≤50th, 51–75th, and >75th SIS% groups, respectively; P 75th SIS% group; P <0.01 for both). Conclusions— We have developed clinically pragmatic age- and sex-specific nomograms of CAD prevalence using coronary computed tomography angiography findings. Global plaque burden measured using SIS% is predictive of cardiac events independent of traditional risk assessment. Clinical Trial Registration— URL: https://www.clinicaltrials.gov . Unique identifier: NCT01443637.
Naoum et al. (2017) studied this question.